Top in endocrinology: Obstructive sleep apnea, hypertension risk in women
Click Here to Manage Email Alerts
A presenter at the Heart in Diabetes meeting explained how continuous positive airway pressure therapy may not improve the metabolic consequences of obstructive sleep apnea in some patients. It was the top story in endocrinology last week.
Another top story explored the factors that can alter a woman’s risk for hypertension. New data revealed that the risk may be influenced by estrogen dosage, the type of formulation and the number of years since menopause.
Read these and more top stories in endocrinology below:
Metabolic consequences of obstructive sleep apnea persist, despite treatment
Obstructive sleep apnea can predispose a person to hyperglycemia and even type 2 diabetes, yet data show continuous positive airway pressure therapy does not improve markers of glucose dysregulation, according to a speaker. Read more.
Estrogen formulation, dosage and years since menopause influence hypertension risk
Estrogen dosage, the type of formulation and the number of years since menopause may alter a woman’s risk for hypertension, according to data from the Women’s Health Initiative Observational Study published in Menopause. Read more.
Time in range — not HbA1c — should guide most diabetes treatment decisions
Clinicians should consider temporary continuous glucose monitoring for any person with diabetes to assess their time spent in the recommended glucose range as an effective guide for treatment decisions, according to a speaker. Read more.
Common endocrine-disrupting chemicals may inhibit breastfeeding
Women exposed to higher concentrations of a class of endocrine-disrupting chemicals known as perfluoroalkyl and polyfluoroalkyl substances are at increased risk for terminating breastfeeding early, researchers reported. Read more.
Lifestyle intervention failed to sustain BMI reductions for children with obesity
Children with a high BMI who participated in a high-intensity lifestyle intervention program in New Zealand had a lower BMI standard deviation score after 1 year, but the reduction was not sustained at 5 years, according to study data. Read more.